adenosine has been researched along with Primary Graft Dysfunction in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balaskó, M; Czopf, L; Garami, A; Hartmann, P; Hegyi, P; Mátrai, P; Pécz, D; Pétervári, E; Solymár, M; Szabó, D; Szilágyi, ÁL; Tuboly, E; Veres, G; Wagner, J; Wobbe, B | 1 |
Araszkiewicz, A; Grajek, S; Grygier, M; Lesiak, M | 1 |
Geller, DA; Ikeda, A; Murase, N; Nakao, A; Ross, MA; Stolz, DB; Tomiyama, K; Ueki, S | 1 |
Berenguer, M; DeJuan, M; Deusa, S; Lopez-Andujar, R; Mir, J; Montalvá, E; Moya, A; Pareja, E; Prieto, M; San Juan, F | 1 |
Arnaoutakis, GJ; Beaty, CA; Conte, JV; George, TJ; Halushka, MK; Shah, AS | 1 |
1 review(s) available for adenosine and Primary Graft Dysfunction
Article | Year |
---|---|
Compared efficacy of preservation solutions on the outcome of liver transplantation: Meta-analysis.
Topics: Adenosine; Allopurinol; Disaccharides; Electrolytes; Glucose; Glutamates; Glutathione; Graft Survival; Histidine; Humans; Insulin; Liver Transplantation; Mannitol; Odds Ratio; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Primary Graft Dysfunction; Procaine; Raffinose; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome | 2018 |
1 trial(s) available for adenosine and Primary Graft Dysfunction
Article | Year |
---|---|
Intracoronary adenosine administered during aortocoronary vein graft interventions may reduce the incidence of no-reflow phenomenon. A pilot randomised trial.
Topics: Adenosine; Aged; Aged, 80 and over; Female; Humans; Male; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Primary Graft Dysfunction; Prospective Studies; Saphenous Vein; Vasodilator Agents | 2014 |
3 other study(ies) available for adenosine and Primary Graft Dysfunction
Article | Year |
---|---|
Liver graft exposure to carbon monoxide during cold storage protects sinusoidal endothelial cells and ameliorates reperfusion injury in rats.
Topics: Adenosine; Allopurinol; Animals; Carbon Monoxide; Cryopreservation; Cryoprotective Agents; Endothelial Cells; Glutathione; Graft Survival; Hepatitis; Insulin; Kupffer Cells; Liver Transplantation; Male; MAP Kinase Signaling System; Matrix Metalloproteinases; Neutrophils; Organ Preservation; Organ Preservation Solutions; Primary Graft Dysfunction; Raffinose; Rats; Rats, Inbred Lew; Reperfusion Injury | 2009 |
Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Biliary Tract Diseases; Disaccharides; Electrolytes; Female; Glutamates; Glutathione; Graft Survival; Histidine; Humans; Insulin; Liver; Liver Function Tests; Liver Transplantation; Male; Mannitol; Middle Aged; Organ Preservation; Organ Preservation Solutions; Pilot Projects; Postoperative Hemorrhage; Primary Graft Dysfunction; Prospective Studies; Raffinose; Time Factors; Transplantation, Homologous; Vascular Diseases; Young Adult | 2009 |
A novel method of measuring cardiac preservation injury demonstrates University of Wisconsin solution is associated with less ischemic necrosis than Celsior in early cardiac allograft biopsy specimens.
Topics: Adenosine; Adult; Allopurinol; Biopsy; Disaccharides; Electrolytes; Female; Glutamates; Glutathione; Graft Rejection; Heart Failure; Heart Transplantation; Histidine; Humans; Incidence; Insulin; Male; Mannitol; Middle Aged; Multivariate Analysis; Myocardial Reperfusion Injury; Myocardium; Necrosis; Organ Preservation; Organ Preservation Solutions; Primary Graft Dysfunction; Raffinose; Retrospective Studies; Survival Rate; Transplantation, Homologous | 2012 |